AHIMA Approved ICD-10 Trainer
Program Director and Professor, Health Services Administration
Eastern Kentucky University
Needs StatementAll healthcare providers are currently using ICD-9-CM to report diagnosis. In October 2015, they will be required to report ICD-10-CM diagnosis codes, which is a new coding system.
Most healthcare providers are not aware of the specific changes that will occur as a result of ICD-10-CM implementation. Physicians need to be aware of the differences between the systems and the impact on medical documentation.
ObjectivesUpon completion of this activity, participants will be able to:
1. Describe the relationship between documentation in the health record and ICD-10-CM coding assignment
2. Identify strategies to improve clinical documentation needed in the assignment of ICD-10-CM codes
3. Identify steps that need to be taken that will facilitate accurate assignment of ICD-10-CM codes
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Practice-based learning and improvement
Faculty DisclosureNo speakers, planners or content reviewers have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.